Yawen is currently the Head of the Department of Asset Management within China Resources Enterprise Ltd. (CRE), Comvita's largest institutional investor and strategic partner in China. She is responsible for the management of CRE's significant overseas investment portfolio, including Comvita, Scales Corporation and NZ King Salmon. Yawen joined China Resources in 2012 as a Business Director of the Strategy Department of China Resources Holdings Ltd. She has led international M&A transactions and investments in the consumer goods and healthcare sectors. Yawen is currently on the board of Oatly Group AB (OTLY:US listed, Swedish domiciled), Genesis Care (US and Australia), and several Chinese domestic companies. She is also the CEO of China Resource's Verlinvest Health Investment Co. Ltd.
This profile aggregates publicly-available information from 6 source registers for the purpose of cross-platform governance and transparency research. Every fact is sourced from one of the public publications listed below; the aggregation, presentation and any analytical observations are published by NZXplorer.
If anything on this page is wrong, missing context, or warrants a formal right-of-reply, use the dispute & right-of-reply form. Our editorial floor — what we always remove on request, the search-engine indexing policy, and the Privacy Act access / correction routes — is set out on Data Principles.